Luye Pharma Group Ltd.

Simbol: LYPHF

PNK

0.38625

USD

Tržna cena danes

  • 12.2328

    Razmerje P/E

  • -0.1792

    Razmerje PEG

  • 1.45B

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Luye Pharma Group Ltd. (LYPHF) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Luye Pharma Group Ltd. (LYPHF). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Luye Pharma Group Ltd., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201120102009200820072006200520042003

balance-sheet.row.cash-and-short-term-investments

08522.35544.35510.3
5406.3
5188.1
4862.6
3841.4
2747.4
3206.4
2177.3
343.1
330.5
454.6
320.4
118.5
142.9
95.6
70.4
132.7
54.1

balance-sheet.row.short-term-investments

02867.53220.53072.1
1540.9
2862.6
3189.7
2575.5
2349.6
2362.7
1845.4
10
79
54.5
45.1
0
0
0
0
0
0

balance-sheet.row.net-receivables

02354.91783.71765.1
1553.1
1813
0
0
0
0
0
0
493.4
366.6
355.6
269.5
233.9
169.8
138.3
95.8
72.3

balance-sheet.row.inventory

0827.9772.9746.3
612.3
614.6
585.6
420.4
452.7
285.6
251.2
234.7
105.4
73.3
57.6
56
42.3
33.6
29.1
28.6
16.3

balance-sheet.row.other-current-assets

03009.94658.75059.1
3830.7
3763.4
0
0
0
0
0
0
0.9
0.9
1.7
2.2
46.2
36.3
15.9
5.4
19.4

balance-sheet.row.total-current-assets

010703.310785.810396.7
9970.4
9359.8
8675.3
6295.9
5282.5
5071.4
3526
1652.4
930.2
895.4
735.4
446.3
465.3
335.4
253.8
262.5
162.2

balance-sheet.row.property-plant-equipment-net

05127.24909.14594.5
4339.3
4213.4
3195.6
2463.9
1969.5
1430.8
1320.6
1162.1
669.7
319.4
205
152.4
147.1
106.7
114.9
94.6
99.6

balance-sheet.row.goodwill

01041.91003.4985.4
1056.6
1038.1
1040.9
1036.9
995.9
347.4
347.4
347.4
359.4
188.2
188.2
165.9
168.7
44.4
5.9
0
0

balance-sheet.row.intangible-assets

06317.95984.75441.8
4770
4486.9
4445.1
828.7
855.7
126.2
145.9
136.3
406.5
340.5
367.1
200.4
222.1
48
8.7
9.4
10.3

balance-sheet.row.goodwill-and-intangible-assets

07359.86988.16427.2
5826.6
5524.9
5485.9
1865.6
1851.6
473.6
493.2
483.7
765.8
528.7
555.3
366.3
390.8
92.4
14.6
9.4
10.3

balance-sheet.row.long-term-investments

01968.4-2106.4-2489.9
-1469.4
-2790.8
-3106.1
-2534.7
-2341.1
-2355
-1837.7
-0.3
-72.9
-47
-40.5
0
119.6
9.1
4.5
0.5
0.5

balance-sheet.row.tax-assets

0144.6113.9133.1
114.7
93.9
98.4
94.2
93.8
69.4
83.3
79.4
58.5
22.9
21.3
6.9
5.1
1
0.5
0.7
0.2

balance-sheet.row.other-non-current-assets

0187.43559.13520.4
1848.9
2912.6
3189.7
5151
4699.2
4725.4
5090.8
20.6
206.3
205.5
94.8
94.8
125
303.7
9.2
5.9
1.2

balance-sheet.row.total-non-current-assets

014787.413463.812185.4
10660.1
9954.1
8863.5
4464.5
3923.4
1981.5
2604.8
1735.1
1524.2
926.8
788.6
620.5
668
503.8
139.2
110.6
111.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

025490.724249.622582.1
20630.6
19313.9
17538.8
10760.4
9205.8
7052.9
6130.8
3387.5
2454.4
1822.2
1524
1066.7
1133.3
839.2
393
373
273.5

balance-sheet.row.account-payables

0767.2559.9570.9
485.3
298.5
279.8
104.6
116.1
83.2
59
69.4
34.3
20.3
13.4
11.7
8.3
9.1
9.8
9.5
12

balance-sheet.row.short-term-debt

05195.86839.85263.2
5642.9
3943.6
5290.5
2861.1
1623.7
502.2
304.9
735.9
453.8
264.1
170.7
65.8
137.3
28.9
10.7
49
88

balance-sheet.row.tax-payables

0294.9256.3205.1
358.1
260.2
223.8
249.4
216.5
159.4
122.5
100.4
32
12.3
9.7
3.6
1
0
0
0
0

balance-sheet.row.long-term-debt-total

03228.22264.74227.6
4338.6
4122.3
847.6
0.2
0.4
0.5
0.6
9.4
2
1.3
30
74.9
115.8
0
0
8
37

Deferred Revenue Non Current

0103.6175209.4
185.7
131.9
149.6
107.6
147.3
115.2
106.6
78.7
2.5
2.4
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

02193.42087.51496.1
1106
17.5
42.1
689.1
634.9
460
524.3
497.7
402.8
174.6
139.7
61.2
68.6
69.6
20.5
19.6
27.7

balance-sheet.row.total-non-current-liabilities

03824.43720.76138
5297.5
4395.6
1401.9
209.7
269.1
208
205
186.8
159
115
105.4
106.1
142.6
3.5
2.5
11.6
42.6

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

070.638.542
24.7
29
0.2
0.4
0.5
0.6
0.1
0.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

011962.213207.913468.2
12531.6
9942.1
9604.8
3864.5
2643.8
1253.4
1093.2
1489.8
1050
574
429.2
244.9
356.8
111.1
43.5
89.7
170.4

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0486.1457455.8
418
420.6
421.3
427.3
427.3
427.3
427.3
81.2
81.2
81.2
81.2
81.2
0
0
0
0
0

balance-sheet.row.retained-earnings

006667.36061.8
6209.3
5688.4
0
0
2667.2
1930.9
1206.8
992.1
585.6
460.5
478.1
312.1
14.4
0
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

07885.8254.5534
501.5
381.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

04159.32797.31436.4
762.4
2733.3
7387.1
6341.1
3334
3305.8
3273.6
695.8
610.4
584.8
428
428
761.5
0
0
0
0

balance-sheet.row.total-stockholders-equity

012531.2101768488.1
7891.2
9224.2
7808.4
6768.4
6428.5
5664
4907.6
1769
1277.2
1126.4
987.3
821.3
775.9
727.6
345
272.1
96.3

balance-sheet.row.total-liabilities-and-stockholders-equity

025490.724249.622582.1
20630.6
19313.9
17538.8
10760.4
9205.8
7052.9
6130.8
3387.5
2454.4
1822.2
1524
1066.7
1133.3
839.2
393
373
273.5

balance-sheet.row.minority-interest

0997.3865.8625.8
207.8
147.7
125.6
127.5
133.5
135.6
130
128.7
127.2
121.7
107.4
0.6
0.6
0.6
4.5
11.3
6.9

balance-sheet.row.total-equity

013528.511041.79113.9
8099
9371.8
7934
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

01968.41114.1582.2
71.5
71.9
83.6
40.8
8.5
7.7
7.7
9.7
6.1
7.5
4.7
92
119.6
9.1
4.5
0.5
0.5

balance-sheet.row.total-debt

08423.99104.59490.8
9981.5
8065.9
6138.1
2861.4
1624.1
502.7
305.5
745.3
455.8
265.5
200.7
140.8
253.1
28.9
10.7
57
125

balance-sheet.row.net-debt

02769.16780.87052.5
6116.1
5740.4
4465.3
1595.5
1226.3
-341
-26.3
412.2
204.3
-134.7
-74.6
22.3
110.2
-66.6
-59.7
-75.7
70.9

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Luye Pharma Group Ltd. opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201120102009200820072006200520042003

cash-flows.row.net-income

0669.8-74.6942.2
1771.7
1473.5
1116.3
974.7
898.1
725.5
383.2
201.1
195.4
166.2
0
0
0
0
0
0

cash-flows.row.depreciation-and-amortization

0671.3582510.9
442
317.2
249.8
140.9
115.2
110.4
100.4
79
70.2
44.8
0
41.2
15.1
11.7
11.1
10.3

cash-flows.row.deferred-income-tax

0-442.9-311.9-505.9
-422.5
-411.5
-317.5
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

025.45050.9
64.7
31.3
6.3
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0319.8-418.1-300.3
-289.6
-486.2
-113.6
-308.4
-410.2
-375.5
38.1
113
50.9
-13.3
0
5.3
-4.8
-39.8
-38.5
-19.5

cash-flows.row.account-receivables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-26.6-1344.9
-29
-165.3
32.3
-43.1
-34.4
-16.5
-92
-9.2
-14.5
3.9
0
3.5
-4.5
-0.7
-12.3
-3.3

cash-flows.row.account-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0346.4-284-305.2
-260.6
-320.9
-145.9
-265.4
-375.8
-359.1
130.1
122.1
65.4
-17.2
0
1.7
-0.3
-39.1
-26.3
-16.2

cash-flows.row.other-non-cash-items

0410.4355335.7
178.7
121.3
-294.6
-215.2
-208.4
-141.3
-83.1
-68
-62.3
-34.6
0
92.1
40.7
70.9
75.5
49.6

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-1163.7-1541.6-1519.9
-3223
-2484.5
-625.2
-319.1
-208.1
-289.3
-270.9
-338.2
-140.6
-24.5
-44.3
-14
-9.4
-29.4
-11.5
-13.2

cash-flows.row.acquisitions-net

0-419-808.5-450.8
-2085.1
-1655.2
-5.4
-1674.5
700
-700
2.1
-271.9
-46.2
1.3
0.4
-167.1
0
0
0
0

cash-flows.row.purchases-of-investments

0-3485.9-3975.7-2859.2
-3073.6
-3958.8
-4676.4
-4554
-5919.3
-1840.5
-10
0
0
-45.1
0
0
0
-4
0
0

cash-flows.row.sales-maturities-of-investments

02899.519194153.8
3397.3
3326.1
4498.1
4610.6
5655.1
25.9
1
0
0
0.2
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0510.8970.7814.2
2292.8
1774.7
-46.5
90.7
8.7
-183.1
-275.1
-73.9
-21.6
-0.7
35.6
2.7
-336
-11.7
-3.6
-3.5

cash-flows.row.net-cash-used-for-investing-activites

0-1658.3-3436138.2
-2691.5
-2997.7
-743.7
-1834.9
240.3
-2978.8
-553.4
-643.1
-191.1
-66.2
-3.6
-178.3
-344.4
-44.6
-15.1
-12.7

cash-flows.row.debt-repayment

0-8301.9-7536.7-5896.7
-6739.2
-5943.1
-2629.6
-2282.8
-1294.3
-2187
-1023.9
-448.7
-295.1
-164.7
-203
-161.8
-59
-49
-110
-106.3

cash-flows.row.common-stock-issued

0189.21044.57326.7
8828.8
1.6
-281.2
0
0
3139.3
0
0
0
0
0
161.8
320.4
0
104.1
0

cash-flows.row.common-stock-repurchased

000-78
-8.8
-21.6
-178.1
0
0
0
0
0
-3.1
0
0
-2
59
0
42
0

cash-flows.row.dividends-paid

000-175.5
-376.8
-289.7
-212.6
-107
0
0
0
0
0
0
-14.4
-19.1
-16.5
-14.3
-0.8
-17.4

cash-flows.row.other-financing-activites

08166.98371.1-922.6
-97.2
8657.4
4034
3209.8
1345.6
1705.5
1111.2
618.2
359.9
224.6
90.7
270.1
73.6
2.7
52.3
127.4

cash-flows.row.net-cash-used-provided-by-financing-activities

054.11878.9254
1606.8
2404.6
732.6
820
51.3
2657.8
87.3
169.5
61.7
59.9
-126.7
87.1
318.6
-60.6
45.6
3.7

cash-flows.row.effect-of-forex-changes-on-cash

0-164.1-52.4112.4
-7.5
-45.5
-84.9
-23
5.5
0.6
-3.5
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-114.5-1427.11538
652.6
407
868.1
-445.9
691.8
-1.3
-30.9
-148.6
124.8
156.8
-24.4
47.3
25.2
-62.3
78.5
31.4

cash-flows.row.cash-at-end-of-period

02323.72438.33865.4
2325.4
1672.9
1265.9
397.8
843.7
331.9
333.1
251.5
400.1
275.3
118.5
142.9
95.6
70.4
132.7
54.1

cash-flows.row.cash-at-beginning-of-period

02438.33865.42327.3
1672.9
1265.9
397.8
843.7
151.9
333.1
364
400.1
275.3
118.5
142.9
95.6
70.4
132.7
54.1
22.8

cash-flows.row.operating-cash-flow

01653.8182.41033.4
1744.9
1045.6
964.1
592
394.7
319.1
438.6
325
254.2
163.2
105.9
138.5
51
42.9
48
40.3

cash-flows.row.capital-expenditure

0-1163.7-1541.6-1519.9
-3223
-2484.5
-625.2
-319.1
-208.1
-289.3
-270.9
-338.2
-140.6
-24.5
-44.3
-14
-9.4
-29.4
-11.5
-13.2

cash-flows.row.free-cash-flow

0490.1-1359.2-486.4
-1478.1
-1438.9
338.9
272.9
186.6
29.8
167.7
-13.2
113.6
138.6
61.6
124.5
41.6
13.5
36.5
27.2

Vrstica izkaza poslovnega izida

Prihodki Luye Pharma Group Ltd. so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja LYPHF znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201120102009200820072006200520042003

income-statement-row.row.total-revenue

06143.15981.75200.2
5539.6
6357.6
5173.4
3814.8
2917.8
2563.1
3154.2
2515.1
1774.4
1340.9
954.8
651
509
308.3
344.4
315.4
238.1

income-statement-row.row.cost-of-revenue

01938.91841.11803.5
1549
1478.7
1124
851.5
535
475.7
482.5
413.5
301.1
204.2
136
85.9
80.2
63.5
76.5
105
108

income-statement-row.row.gross-profit

04204.24140.53396.7
3990.6
4878.9
4049.4
2963.4
2382.7
2087.4
2671.7
2101.6
1473.3
1136.6
818.8
565.1
428.8
244.8
267.9
210.4
130.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00.3-22-62.1
1.2
11.9
7.8
3.9
3.1
3.3
0.7
-0.2
0
1.1
11.6
13
-10
4.9
-1
-6.3
-6.9

income-statement-row.row.operating-expenses

03175.43186.63113.9
2775.4
3019.2
2532.6
1872.5
1468
1256.5
1946.8
1687.8
1257.9
934.8
656.8
484.2
351.8
164.2
176.5
128.4
72.1

income-statement-row.row.cost-and-expenses

05114.45027.84917.4
4324.4
4497.8
3656.6
2724
2003.1
1732.2
2429.4
2101.3
1559
1139
792.8
570.1
432
227.7
253
233.4
180.1

income-statement-row.row.interest-income

0117.188.7102
110.4
95.9
62.7
27.6
47.7
21.8
25.2
3
4.8
3.8
2.6
3.2
0
0
0
0
0

income-statement-row.row.interest-expense

0675.5471.8399.5
424
274.6
170.6
50.4
30.4
15.6
39.5
23.9
19.6
11.3
9.9
14.2
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-187.3-545.2-461.5
-476.8
-218.3
-152.9
13.8
-228.4
-205.5
-39.3
-23.1
-19.6
-6.5
4.2
1.9
-10
4.9
-1
-6.3
-6.9

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00.3-22-62.1
1.2
11.9
7.8
3.9
3.1
3.3
0.7
-0.2
0
1.1
11.6
13
-10
4.9
-1
-6.3
-6.9

income-statement-row.row.total-operating-expenses

0-187.3-545.2-461.5
-476.8
-218.3
-152.9
13.8
-228.4
-205.5
-39.3
-23.1
-19.6
-6.5
4.2
1.9
-10
4.9
-1
-6.3
-6.9

income-statement-row.row.interest-expense

0675.5471.8399.5
424
274.6
170.6
50.4
30.4
15.6
39.5
23.9
19.6
11.3
9.9
14.2
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

0701.9671.3582
510.9
442
317.2
249.8
140.9
115.2
110.4
100.4
79
70.2
44.8
16.1
41.2
15.1
11.7
11.1
10.3

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0887.41215387
1419
1989.9
1626.3
1102.5
1203.1
1103.6
764.8
406.3
220.8
201.9
162
80.8
77
80.6
91.4
82
58

income-statement-row.row.income-before-tax

0700.1669.8-74.6
942.2
1771.7
1473.5
1116.3
974.7
898.1
725.5
383.2
201.1
195.4
166.2
82.8
67
85.5
90.4
75.7
51.1

income-statement-row.row.income-tax-expense

016186.570.2
238.9
279.8
167.5
135.8
80.7
133.4
111.1
55.2
34.9
45
37
20.7
8
4.6
0.2
-0.5
6.3

income-statement-row.row.net-income

0532.6604.8-134.4
706.6
1468.6
1303.4
981.4
891.5
754.5
605.5
310.5
151.6
136.1
123.5
62.1
59
80.9
90.2
71.8
42.6

Pogosto zastavljeno vprašanje

Kaj je Luye Pharma Group Ltd. (LYPHF) skupna sredstva?

Luye Pharma Group Ltd. (LYPHF) skupna sredstva so 25490715000.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.678.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je 0.053.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je 0.090.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so 0.138.

Kaj je Luye Pharma Group Ltd. (LYPHF) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je 532605000.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 8423947000.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 3175450000.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.